A new study identifies DDX6 as a regulator of RNA editing that suppresses innate immune sensing in cancer. Depleting DDX6 increased dsRNA accumulation and immune cell infiltration, revealing a potential pathway for future cancer immunotherapies. The post Unexpected Role for RNA Editing in Cancer Immune Evasion Uncovered appeared first on Inside Precision Medicine .